雌激素在慢性肝病发生发展中的作用研究现状*

doi:10.3969/j.issn.1672-5069.2015.05.033

Abstract

Zhao Lei， Zhang Wei. Changes of serum estrogen and estrogen receptors in patients with chronic liver diseases[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2015, 18(5): 563-566.

[1] Abdel-Hady M，Kelly D. Chronic hepatitis B in children and dolescents:Epidemiology and management. Pediatr Drugs，2013，15（4）:311-317.
[2] Ott JJ，Stevens GA，Groeger J，et al. Global epidemiology of hepatitis B virus infection:new estimates of age-specific HBsAg seroprevalence and endemicity. Vaccine，2012，30（12）:2212-2219. [3] Khan F，Shams S，Qureshi ID，et al. Hepatitis B virus infection among different sex and age groups in Pakistani Punjab. Virol J，2011，8:225-229.
[4] Shimizu I，Ito S. Protection of estrogens against the progression of chronic liver disease. Hepatol Res，2007，37（4）:239-247.
[5] Ronghe A，Chatterjee A，Singh B，et al. Differential regulation of estrogen receptors a and b by 4-（E）-{（4-hydroxyphenylimino）-methylbenzene，1，2-diol}，a novel resveratrol analog. J Steroid Biochem Mol Biol，2014，144:500-512.
[6] Wang SH，Yeh SH，Lin WH，et al. Estrogen receptor α represses transcription of HBV genes via interaction with hepatocyte nuclear factor 4α. Gastroenterology，2012，142（4）:989-998.
[7] Lavanchy D. Evolving epidemiology of hepatitis C virus. Clin Microbiol Infect，2011，17（2）:107-115.
[8] Cai L，Gao C，Tang S，et al. Sex-specific association of estrogen receptor 2 polymorphisms with hepatitis C virus infection outcomes in a high-risk Chinese Han population. Infect Genet Evol，2014，28:118-124.
[9] Baden R，Rockstroh JK，Buti M. Natural history and management of hepatitis C:Does sex play a role J Infect Dis，2014，209（3）:81-85.
[10] Nanda KS，Brady JJ，Murray BF，et al. Elevated circulating osteoprotegerin and reduced matrix-metalloprotease-9 in post-menopausal women with chronic Hepatitis C virus infection. Cytokine，2012，60（2）:328-333.
[11] Villa E，Cammà C，Di Leo A，et al. Peginterferon-A-2B plus ribavirin is more effective than peginterferon-A-2A plus ribavirin in menopausal women with chronic hepatitis C. J Viral Hepat，2012，19（9）:640-649.
[12] Tang S，Yue M，Wang J，et al. Association of genetic variants in estrogen receptor α with HCV infection susceptibility and viral clearance in a high-risk Chinese population. Eur J Clin Microbiol Infect Dis，2014，33（6）:999-1010.
[13] Murakami Y，Fukasawa M，Kaneko Y，et al. Selective estrogen receptor modulators inhibit hepatitis C virus infection at multiple steps of the virus life cycle. Microbes Infect，2013，15（1）:45-55.
[14] Jemal A，Bray F，Center MM，et al. Global cancer statistics. CA Cancer J Clin，2011，61（2）:69-90.
[15] Oishi K，Itamoto T，Kohashi T，et al. Safety of hepatectomy for elderly patients with hepatocellular carcinoma. World J Gastroenterol，2014，20（41）:15028-15036.
[16] Dai B，Geng L，Yu Y，et al. Methylation patterns of estrogen receptor a promoter correlate with estrogen receptor a expression and clinicopathological factors in hepatocellular carcinoma. Exp Biol Med，2014，239（7）:883-890.
[17] Villa E. Role of estrogen in liver cancer. Women’s Health， 2008，4:41-50.
[18] Li T，Qin LX，Gong X，et al. Clinical characteristics，outcome， and risk factors for early and late intrahepatic recurrence of female patients after curative resection of hepatocellular carcinoma. Surgery，2014，156（3）:651-660.
[19] Liu WC，Liu QY. Molecular mechanisms of gender disparity in hepatitis B virus-associated hepatocellular carcinoma. World J Gastroenterol，2014，20（20）:6252-6261.
[20] Shi L，Feng Y，Cai X，et al. Role of estrogen in hepatocellular carcinoma:is inflammation the key J Transl Med，2014，12:93-101.
[21] Heneghan MA，Yeoman AD，Verma S，et al. Autoimmune hepatitis. Lancet，2013，382（9902）:1433-1444.
[22] Liberal R，Grant CR，Longhi MS，et al. Diagnostic criteria of autoimmune hepatitis. Autoimmun Rev，2014，13（4-5）:435-440.
[23] Ferguson LA. Autoimmune hepatitis:A noninfectious killer. J Am Assoc Nurse Pract，2014，26（1）:13-18.
[24] Werner M，Bjrnsson E，Prytz H，et al. Autoimmune hepatitis among fertile women:Strategies during pregnancy and breastfeeding Scand J Gastroenterol，2007；42（8）:986-991.
[25] Mizoguchi Y，Ikemoto Y，Yamamoto S，et al. Studies on the effects of estrogen on in vitro antibody production in autoimmune liver diseases，including lupoid hepatitis and primary biliary cirrhosis. Gastroenterol Jpn， 1985， 20（3）:229–233.
[26] Flores A，Mayo MJ. Primary biliary cirrhosis in 2014. Curr opin Gastroenterol，2014，30（3）:245-252.
[27] Momah N，Lindor KD. Primary biliary cirrhosis in adults. Expert Rev Gastroenterol Hepatol，2014，8（4）:427-433.
[28] Lleo A，Oertelt-Prigione S，Bianchi I，et al. Y chromosome loss in male patients with primary biliary cirrhosis. J Autoimmun， 2013，41:87–91.
[29] Marrone J，Lehmann GL，Soria LR，et al. Adenoviral transfer of human aquaporin-1 gene to rat liver improves bile flow in estrogen-induced cholestasis. Gene Ther，2014，21（12）:1058-1064.
[30] Czul F，Peyton A，Levy C. Primary biliary cirrhosis:therapeutic advances. Clin Liver Dis，2013，17（2）:229-242.
[31] Sipil S，Finni T，Kovanen V. Estrogen influences on neuromuscular function in postmenopausal women. Calcif Tissue Int， 2014， 96（3）:222-233.
[32] 王磊，李青梅，杜慧慧，等. 原发性胆汁性肝硬化患者肝脏雌激素受体与外周血细胞因子及自身抗体的相关性研究. 中华肝脏病杂志， 2012，20（5）:336-339.
[33] Alvaro D，Invernizzi P，Onori P，et al. Estrogen receptors in cholangiocytes and the progression of primary biliary cirrhosis. J Hepatol，2004，41（6）:905-912.
[34] Sun Y，Haapanen K，Li B，et al. Women and primary biliary cirrhosis. Clin Rev Allergy Immunol，2014，DOI:10.1007/s12016-014-8449-4.
[35] Efe C，Kahramanolu-Aksoy E，Yilmaz B，et al. Pregnancy in women with primary biliary cirrhosis. Autoimmun Rev，2014，13（9）:931-935.

Changes of serum estrogen and estrogen receptors in patients with chronic liver diseases

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	Tang Renyi, Hu Qunfeng, Peng Liqing.. Changes of serum lipids, liver function tests and estrogen levels in patients with intrahepatic cholestasis of pregnancy and its clinical significance [J]. Journal of Practical Hepatology, 2019, 22(6): 860-863.
[2]	Liao Guichan, Peng Jie, Zhang Xiaoyong. Roles of hepatocytes in intrinsic innate immunity in control of hepatits B virus infection [J]. Journal of Practical Hepatology, 2019, 22(5): 617-619.
[3]	Liu Xing, Zhao Shuli, Zhang Dianlong. Effect of sevoflurane inhalation on hepatic ischemia-reperfusion injury in patients with primary liver cancer undergoing partial hepatectomy [J]. Journal of Practical Hepatology, 2019, 22(5): 728-731.
[4]	Tang Chengwei. Chronic liver disease and thrombocytopenia：Changes in clinical management concept [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 457-458.
[5]	Pei Ying, Huang Feng, Yin Hongzhen, et al. Preliminary study on intestinal microecology in mice with xenograft hepatoma intervened by sodiumnorcantharidate [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 486-489.
[6]	Bai Yichun, Deng Jihong, Mei Xiaoping. Efficacy of peginterferon alfa-2b treatment and affecting response factors in patients with chronic hepatitis B [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 490-493.
[7]	Dai Qingyun, Wang Rundong, Jia Weidong. Prediction of early tumor recurrence by predictive nutritional index in patients with hepatocellular carcinoma undergoing hepatectomy [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 561-564.
[8]	Cui Faqiang, Li Tao, Wang Zheng, et al. A pilot study on cetuximab and KRAS gene mutation in treatment of patients with primary liver cancer [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 565-568.
[9]	Yang Fucun, Shang Huaixue, Gai Yonghao. Enhanced magnetic resonance imaging by gadolinium disodium sebacate in diagnosis of patients with focal liver lesions [J]. Journal of Practical Hepatology, 2019, 22(4): 577-580.
[10]	Peng Xinjian, Xiao Yuhui, Xu Siding. Diagnostic value of diffusion-weighted magnetic resonance imaging in patients with radiation-induced liver injury with underlying hepatocelullar carcinoma [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(3): 373-376.
[11]	Zhao Xiaoguang, Shi Yujie. Protective effect of reduced glutathione on liver function in patients with advanced primary liver cancer underwent transarterial chemoembolization [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(3): 425-428.
[12]	Wu Jing, Dong Baoji, Wu Chao. Comparison of PD-1 receptor on peripheral blood follicular helper T lymphocyte surface in chronic hepatitis C patients with low and high serum viral loads [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(2): 192-195.
[13]	Lin Lan, Shen Min, Ruan Jianwen.. Expression of programmed death receptor 1 in liver tissue of patients with autoimmune hepatitis and its clinical implications [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(2): 204-207.
[14]	Li Ketian, Shen Mingge, Wang Fengrong, Hu Chunrong, Cao Yujie, Lu Peng. Impact of blood glucose levels on imaging quality of PET/CT examination in patients with primary liver cancer [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(2): 256-259.
[15]	Zhang Bangjian, Wei Shoucun, Yang Xiaoyan. Effects of dexmedetomidine combined with propofol anesthesia on perioperative stress response and postoperative recovery quality in patients undergoing hepatectomy [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(2): 264-267.